Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia
Abstract Tardive dyskinesia (TD) is a serious motor side effect that may appear after long-term treatment with neuroleptics and mostly mediated by dopamine D2 receptors (D2Rs). Striatal D2R functioning may be finely regulated by either adenosine A2A receptor (A2AR) or angiotensin receptor type 1 (AT...
Guardado en:
Autores principales: | Paulo A. de Oliveira, James A. R. Dalton, Marc López-Cano, Adrià Ricarte, Xavier Morató, Filipe C. Matheus, Andréia S. Cunha, Christa E. Müller, Reinaldo N. Takahashi, Víctor Fernández-Dueñas, Jesús Giraldo, Rui D. Prediger, Francisco Ciruela |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/627f7a95432f4193ae2fb95d8887e02b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of neurolept-induced tardive dyskinesia
por: Jankelowitz SK
Publicado: (2013) -
Tardive Dyskinesia in Older Persons Taking Antipsychotics
por: Citrome L, et al.
Publicado: (2021) -
Overcoming barriers to effective management of tardive dyskinesia
por: Caroff SN
Publicado: (2019) -
Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?
por: Hu JB, et al.
Publicado: (2017) -
Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations
por: Jackson R, et al.
Publicado: (2021)